137 related articles for article (PubMed ID: 33315798)
1. A 3-Month Naturalistic Follow-Up Treatment With Selective Serotonin Reuptake Inhibitors in Frequent Attenders of General Medical Practice: What Correlates With a Good Response?
Carmassi C; Cappelli A; Dell'Oste V; Amatori G; Bertelloni CA; Massimetti G; Nisita C; Dell'Osso L
J Nerv Ment Dis; 2021 Apr; 209(4):275-282. PubMed ID: 33315798
[TBL] [Abstract][Full Text] [Related]
2. Frequent attenders in general medical practice in Italy: a preliminary report on clinical variables related to low functioning.
Carmassi C; Dell'Oste V; Ceresoli D; Moscardini S; Bianchi E; Landi R; Massimetti G; Nisita C; Dell'Osso L
Neuropsychiatr Dis Treat; 2019; 15():115-125. PubMed ID: 30636877
[TBL] [Abstract][Full Text] [Related]
3. The impact of antidepressants on seizure frequency and depressive and anxiety disorders of patients with epilepsy: Is it worth investigating?
Ribot R; Ouyang B; Kanner AM
Epilepsy Behav; 2017 May; 70(Pt A):5-9. PubMed ID: 28407526
[TBL] [Abstract][Full Text] [Related]
4. Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care: the THREAD (THREshold for AntiDepressant response) study.
Kendrick T; Chatwin J; Dowrick C; Tylee A; Morriss R; Peveler R; Leese M; McCrone P; Harris T; Moore M; Byng R; Brown G; Barthel S; Mander H; Ring A; Kelly V; Wallace V; Gabbay M; Craig T; Mann A
Health Technol Assess; 2009 Apr; 13(22):iii-iv, ix-xi, 1-159. PubMed ID: 19401066
[TBL] [Abstract][Full Text] [Related]
5. Relationships Between Somatic Symptoms and Panic-Agoraphobic Spectrum Among Frequent Attenders of the General Practice in Italy.
Carmassi C; Dell'Oste V; Cordone A; Pedrinelli V; Cappelli A; Ceresoli D; Massimetti G; Nisita C; Dell'Osso L
J Nerv Ment Dis; 2020 Jul; 208(7):540-548. PubMed ID: 32205774
[TBL] [Abstract][Full Text] [Related]
6. Use of benzodiazepines and selective serotonin reuptake inhibitors in middle-aged and older adults with anxiety disorders: a longitudinal and prospective study.
Benítez CI; Smith K; Vasile RG; Rende R; Edelen MO; Keller MB
Am J Geriatr Psychiatry; 2008 Jan; 16(1):5-13. PubMed ID: 18165458
[TBL] [Abstract][Full Text] [Related]
7. Selective Serotonin Reuptake Inhibitor Monotherapy for Anxiety Disorders in Children and Adolescents with Autism Spectrum Disorder: A Chart Review.
Thorkelson G; Laughlin SF; Turner KS; Ober N; Handen BL
J Child Adolesc Psychopharmacol; 2019 Nov; 29(9):705-711. PubMed ID: 31295004
[No Abstract] [Full Text] [Related]
8. Pregabalin versus sertraline in generalized anxiety disorder. An open label study.
Cvjetkovic-Bosnjak M; Soldatovic-Stajic B; Babovic SS; Boskovic K; Jovicevic M
Eur Rev Med Pharmacol Sci; 2015; 19(11):2120-4. PubMed ID: 26125277
[TBL] [Abstract][Full Text] [Related]
9. Pilot of a randomised controlled trial of the selective serotonin reuptake inhibitor sertraline versus cognitive behavioural therapy for anxiety symptoms in people with generalised anxiety disorder who have failed to respond to low-intensity psychological treatments as defined by the National Institute for Health and Care Excellence guidelines.
Buszewicz M; Cape J; Serfaty M; Shafran R; Kabir T; Tyrer P; Clarke CS; Nazareth I
Health Technol Assess; 2017 Aug; 21(45):1-138. PubMed ID: 28853392
[TBL] [Abstract][Full Text] [Related]
10. The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month.
Salisbury AL; O'Grady KE; Battle CL; Wisner KL; Anderson GM; Stroud LR; Miller-Loncar CL; Young ME; Lester BM
Am J Psychiatry; 2016 Feb; 173(2):147-57. PubMed ID: 26514656
[TBL] [Abstract][Full Text] [Related]
11. Real-world outcomes in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia.
Hong J; Novick D; Montgomery W; Moneta MV; Dueñas H; Peng X; Haro JM
Asia Pac Psychiatry; 2016 Mar; 8(1):51-9. PubMed ID: 25808275
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disorders.
Nutt DJ; Forshall S; Bell C; Rich A; Sandford J; Nash J; Argyropoulos S
Eur Neuropsychopharmacol; 1999 Jul; 9 Suppl 3():S81-6. PubMed ID: 10523062
[TBL] [Abstract][Full Text] [Related]
13. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
[TBL] [Abstract][Full Text] [Related]
14. Treatment-emergent suicidal ideation during 4 months of acute management of unipolar major depression with SSRI pharmacotherapy or interpersonal psychotherapy in a randomized clinical trial.
Rucci P; Frank E; Scocco P; Calugi S; Miniati M; Fagiolini A; Cassano GB
Depress Anxiety; 2011 Apr; 28(4):303-9. PubMed ID: 21308882
[TBL] [Abstract][Full Text] [Related]
15. Differences in total medical costs across the SSRIs for the treatment of depression and anxiety.
Sheehan DV; Eaddy MT; Shah MB; Mauch RP
Am J Manag Care; 2005 Oct; 11(12 Suppl):S354-61. PubMed ID: 16236017
[TBL] [Abstract][Full Text] [Related]
16. A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder.
Dannon PN; Iancu I; Lowengrub K; Gonopolsky Y; Musin E; Grunhaus L; Kotler M
Clin Neuropharmacol; 2007; 30(6):326-34. PubMed ID: 18090457
[TBL] [Abstract][Full Text] [Related]
17. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
Goodyer IM; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
Health Technol Assess; 2008 May; 12(14):iii-iv, ix-60. PubMed ID: 18462573
[TBL] [Abstract][Full Text] [Related]
18. The Relationship Between Plasma Cytokine Levels and Response to Selective Serotonin Reuptake Inhibitor Treatment in Children and Adolescents with Depression and/or Anxiety Disorders.
Amitai M; Taler M; Carmel M; Michaelovsky E; Eilat T; Yablonski M; Orpaz N; Chen A; Apter A; Weizman A; Fennig S
J Child Adolesc Psychopharmacol; 2016 Oct; 26(8):727-732. PubMed ID: 26771135
[TBL] [Abstract][Full Text] [Related]
19. [Psychiatric and psychological aspects of premenstrual syndrome].
Limosin F; Ades J
Encephale; 2001; 27(6):501-8. PubMed ID: 11865558
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a meta-analysis of double-blind, placebo-controlled trials.
Hedges DW; Brown BL; Shwalb DA; Godfrey K; Larcher AM
J Psychopharmacol; 2007 Jan; 21(1):102-11. PubMed ID: 16714326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
